Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|6|1028-1035

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.6, 2015-06, pp. : 1028-1035

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Venous Thromboembolism in Cancer Patients

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 66-70

Karger

Access to resources Recommend Favorite

Treatment of Venous Thromboembolism in Ambulatory Cancer Patients in Germany: A Prospective Non-Interventional Study

By  

Oncology Research and Treatment, Vol. 38, Iss. 4, 2015-03 ,pp. : 174-180

Karger

Access to resources Recommend Favorite

Practice Patterns for Prophylaxis and Treatment of Venous Thromboembolism in German Cancer Patients

By  

Oncology Research and Treatment, Vol. 39, Iss. 4, 2016-03 ,pp. : 194-201

Karger

Access to resources Recommend Favorite

Should Patients with Venous Thromboembolism and Cancer Be Treated Differently?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 91-97

Karger

Access to resources Recommend Favorite

Prognostic relevance of an asymptomatic venous thromboembolism in patients with cancer

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 9, Iss. 5, 2011-05 ,pp. : 1081-1083

John Wiley & Sons Inc

Access to resources Recommend Favorite